BOCH
CABA icon

Blue Owl Capital Holdings’s Cabaletta Bio CABA Stock Holding History

Blue Owl Capital Holdings’s Portfolio CABA Stock Details CABA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,125,000
Closed -$1.71M – 75
2025
Q2 		$1.71M Buy
+1,125,000
New +$1.75M 0.55% 33

Other funds holding CABA

BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $359M AUM 7.93% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Superstring Capital Management New York $140M AUM 323.19% 1-Year Est. Return

Blue Owl Capital Holdings's CABA Position: Q3 2025 in Review

Blue Owl Capital Holdings sold out of Cabaletta Bio (CABA) in Q3 2025, closing a stake of 1,125,000 shares — an estimated $1.71M sold.

Blue Owl Capital Holdings first reported a position in CABA in Q2 2025 and held it in 1 quarter. The position peaked at $1.71M in Q2 2025. 75 funds tracked by Wall St. Rank hold CABA as of Q3 2025.

  • Blue Owl Capital Holdings reported no remaining Cabaletta Bio position as of Q3 2025 after selling out during the quarter.
  • Blue Owl Capital Holdings sold 1,125,000 Cabaletta Bio shares in Q3 2025, an estimated $1.71M.
  • Blue Owl Capital Holdings first reported a position in Cabaletta Bio in Q2 2025 and held it in 1 quarter.
  • Blue Owl Capital Holdings's Cabaletta Bio position peaked at $1.71M in Q2 2025.
  • 75 funds tracked by Wall St. Rank held Cabaletta Bio as of Q3 2025.

Based on Blue Owl Capital Holdings's 13F filing for Q3 2025, filed 12 Nov 2025.